Long-Term Illness Scheme Coverage

Dáil Éireann Debate, Tuesday - 26 January 2016

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 26 January 2016

Questions (369)

Gerry Adams

Question:

369. Deputy Gerry Adams asked the Minister for Health if he will reimburse costs to persons for the drug Fampyra, who are covered under the general medical services scheme and the long-term illness scheme for the period following the end of the trial until its approval by the Health Service Executive on 1 October 2015, given the considerable financial costs incurred by such persons in need of treatment; and if he will make a statement on the matter. [3134/16]

Written answers

Minister of State at the Department of Health

As you are aware, Fampridine (brand name Fampyra®) has been reimbursed under the Long Term Illness Scheme on a conditional, responder-only basis since 1 October 2015.

It is not possible to reimburse patients retrospectively for any medicine purchased before that medicine is added to the HSE's List of Reimbursable Items.

• Previous Answer
• Next Answer